Fonte: Resumos. Nome do evento: Reunião Anual da Federação de Sociedades de Biologia Experimental. Unidade: FCF
Assuntos: DIABETES MELLITUS, ENDOCRINOLOGIA
ABNT
MARQUES, Milano Felipe dos Santos Ferreira et al. Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone. 2009, Anais.. São Paulo: FeSBE, 2009. . Acesso em: 01 nov. 2024.APA
Marques, M. F. dos S. F., Himelfarb, S. T., Rodrigues, A. C., Silva, F. A., Silva, V. F. da, Mônico, M. I. D., et al. (2009). Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone. In Resumos. São Paulo: FeSBE.NLM
Marques MF dos SF, Himelfarb ST, Rodrigues AC, Silva FA, Silva VF da, Mônico MID, Armaganijan D, Bertolami MC, Hirata RDC, Hirata MH. Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone. Resumos. 2009 ;[citado 2024 nov. 01 ]Vancouver
Marques MF dos SF, Himelfarb ST, Rodrigues AC, Silva FA, Silva VF da, Mônico MID, Armaganijan D, Bertolami MC, Hirata RDC, Hirata MH. Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone. Resumos. 2009 ;[citado 2024 nov. 01 ]